Celator Pharmaceuticals' Series E - III Round

Celator Pharmaceuticals raised a round of funding on May 01, 2013. Investors include Valence Life Sciences.

Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identif…

Articles about Celator Pharmaceuticals' Series E - III Round: